PB2038: LENALIDOMIDE OR BORTEZOMIB AS MAINTENANCE TREATMENT OVERCOMES INFERIOR IMPACT OF HIGH-RISK CYTOGENETIC ABNORMALITIES IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA IN CHINA

oleh: Z. Zhuang, Y. Tian, L. Shi, D. Zou, R. Feng, W.-W. Tian, H. Yu, F. Dong, A. Liao, Y. Ma, Q. Liu, S. Liu, H. Jing, R. Fu, L.-M. Ma, H. Liu, W. Sun, L. Bao, Y. Wu, W. Chen, J. Zhuang